Research Today • Hope For Tomorrow

MK-0431-848

Merck 848

MK-0431-848, Merck 848, is a double blind, placebo controlled clinical trial investigating the efficacy of Metformin alone to Metformin and Sitagliptin in combination on subjects with Type 2 Diabetes Mellitus.

Contact us to learn more